2Byrne RA, Cassese S, Windisch T, et al. Differential relative efficacy between drug-tinting stents in patients with bare metal and drug-eluting stent restenosis ; evidence in support of drug resistance : insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials[J]. Eurolntervention, 2013, 9 ( 7 ) : 797-802.
3Byrne RA, Neumann FJ, Mehilli J, et al. paclitaxel eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent ( 1SAR- DESIRE3 ): a randomised, open-label trial. Lancet, 2013,381( 9865 ): 461-467.